How is the Pasithea Therapeutics Corp today?

The Pasithea Therapeutics Corp today is trading in the down by -2.15% at 0.91.

What is Pasithea Therapeutics Corp Annual Net Profit?

Pasithea Therapeutics Corp Annual Net Profit rose 12.89% in the last year to $13.9 M. Its sector's average net profit growth for the last fiscal year was -12.66%.

What is Pasithea Therapeutics Corp Price to Earning Ratio?

Pasithea Therapeutics Corp Price to Earning Ratio is -0.5, which is negative.

What is Pasithea Therapeutics Corp Stock Price?

Pasithea Therapeutics Corp Stock Price fell 83.33% and underperformed its sector by 114.28% in the past year.

What is Pasithea Therapeutics Corp Quarterly Net profit?

Pasithea Therapeutics Corp Quarterly Net profit rose 7.71% YoY to $3.56 M. Its sector's average net profit growth YoY for the quarter was -235.97%.

What is Pasithea Therapeutics Corp Debt to Equity Ratio?

Pasithea Therapeutics Corp Debt to Equity Ratio is zero as the company is debt-free.

What is Pasithea Therapeutics Corp Return on Equity(ROE)?

Pasithea Therapeutics Corp Return on Equity(ROE) for the last financial year was -72.83%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Pasithea Therapeutics Corp Mutual Fund Holding?

Pasithea Therapeutics Corp Mutual Fund Holding decreased by 0.56% in the last quarter to 4.05.

What is Pasithea Therapeutics Corp Institutional Holding?

Pasithea Therapeutics Corp Institutional Holding increased by 0.34% in the last quarter to 3.7.

Pasithea Therapeutics Corp XNAS: KTTA

Pasithea Therapeutics Corp Live Share Price Today, Share Analysis and Chart

Name: Pasithea Therapeutics Corp: Is Infosys Ltd. worth buying?
Item: Pasithea Therapeutics Corp
Rating: 0.88416675
Author: Trendlyne DVM scores

about

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in ...

0.91 -0.02 (-2.15%)

New 52W Low in past week

298.3K XNAS Volume

XNAS 03 Jun, 2025 2:14 PM (EDT)

Not Eligible

-

Expensive Valuation

16.2 / 100

Technically Bearish

19.2 / 100

No estimates available

Pasithea Therapeutics Corp Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Pasithea Therapeutics Corp FAQ

How is Pasithea Therapeutics Corp today?

Pasithea Therapeutics Corp today is trading in the red, and is down by -2.15% at 0.91.

How has Pasithea Therapeutics Corp performed historically?

Pasithea Therapeutics Corp is currently trading down -2.15% on an intraday basis. In the past week the stock fell -1.09%. stock has been down -21.55% in the past quarter and fell -83.33% in the past year. You can view this in the overview section.